GNMX - Aevi Genomic Medicine Inc.
Previous close
0.1659
0 0%
Share volume: 0
Last Updated: Mon 03 Feb 2020 06:00:00 AM CET
Biotechnology:
-0.86%
PREVIOUS CLOSE
CHG
CHG%
$0.17
0.00
0.00%
Summary score
25%
Profitability
32%
Dept financing
35%
Liquidity
16%
Performance
17%
Sector
Health Technology
Industry
Biotechnology
Long-term ratios 30-Jun-2015 - 30-Jun-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-132.7%
Return on assets
-40.29%
Return on sales
0%
Return on invested capital
175.85%
Total debt ratio
28.92%
Debt ratio change over timeo
-0.8%
Current Ratio
5.34%
Quick Ratio
0%
Cash Position Ratio
5.19%
Short-term ratios 30-Jun-2018 - 30-Jun-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-341.05%
Return on assets
-61.24%
Return on sales
0%
Return on invested capital
122.75%
Total debt ratio
52.55%
Debt ratio change over timeo
-0.61%
Current Ratio
2.25%
Quick Ratio
0%
Cash Position Ratio
2.13%
Last quarter ratios 30-Jun-2019
The data are presented for the financials results of the last quarter.
Return on equity
-1097.89%
Return on assets
-90.75%
Return on sales
0%
Return on invested capital
99.13%
Total debt ratio
91.74%
Debt ratio change over time
-0.26%
Current Ratio
1.09%
Quick Ratio
0%
Cash Position Ratio
0.93%
Performance ratios (change over 4 years) 30-Jun-2015 - 30-Jun-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-204.11%
Return on assets
-126.67%
Return on sales
0%
Return on invested capital
-7.01%
Total debt ratio
-79.9%
Debt ratio change over time
-0.8%
Current Ratio
1.52%
Quick Ratio
0%
Cash Position Ratio
1.44%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GNMX | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -132.7% | -5.61% | -10.5% | -11.67% |
| Return on assets | -40.29% | -20.86% | -8.18% | -9.47% |
| Return on sales | 0% | -5539.23% | 0% | -356.65% |
| Return on invested capital | 175.85% | 354.56% | -245.62% | -123.06% |
| Profitability | 37% | 50% | 25% | 0% |
| Total debt ratio | 28.92% | 135.51% | 24.76% | 24.16% |
| Debt ratio change over time | -0.8% | 0.12% | -1.08% | -1.38% |
| Dept financing | 5% | 50% | 5% | 4% |
| Current Ratio | 2.25% | 11.79% | 7.07% | 7.83% |
| Quick Ratio | 0% | 0% | 0% | 7.46% |
| Cash Position Ratio | 2.13% | 11.51% | 3.1% | 1.63% |
| Liquididy | 33% | 46% | 25% | 59% |
| Short-term ratios | GNMX | IMMU | MNTA | ONCE |
|---|---|---|---|---|
| Return on equity | -341.05% | -42.29% | -17.27% | -12.45% |
| Return on assets | -61.24% | -16.67% | -11.14% | -7.48% |
| Return on sales | 0% | 0% | 0% | -422.62% |
| Return on invested capital | 122.75% | 675.1% | -305.46% | -38.28% |
| Profitability | 30% | 25% | 0% | 50% |
| Total debt ratio | 52.55% | 57.87% | 25.5% | 39.42% |
| Debt ratio change over time | -0.61% | -0.87% | -1.62% | -1.81% |
| Dept financing | 48% | 25% | 11% | 17% |
| Current Ratio | 2.25% | 11.79% | 7.07% | 7.83% |
| Quick Ratio | 0% | 0% | 0% | 7.46% |
| Cash Position Ratio | 2.13% | 11.51% | 3.1% | 1.63% |
| Liquididy | 9% | 50% | 22% | 45% |